Intravenous Artesunate for Severe Malaria in Travelers, Europe

Multicenter trials in Southeast Asia have shown better survival rates among patients with severe malaria, particularly those with high parasitemia levels, treated with intravenous (IV) artesunate than among those treated with quinine. In Europe, quinine is still the primary treatment for severe mala...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoller, Thomas, Junghanss, Thomas, Kapaun, Annette, Gjørup, Ida, Richter, Joachim, Hugo-Persson, Mats, Mørch, Kristine, Foroutan, Behruz, Suttorp, Norbert, Yürek, Salih, Flick, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2011
Materias:
Synopsis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321768/
https://www.ncbi.nlm.nih.gov/pubmed/21529383
http://dx.doi.org/10.3201/eid1705.101229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321768/
https://www.ncbi.nlm.nih.gov/pubmed/21529383
http://dx.doi.org/10.3201/eid1705.101229

Ejemplares similares